Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tug Of War In The LVAD Market

Executive Summary

With the rivalry between Thoratec and HeartWare intensifying in the LVAD space, all eyes are now on recent strategic acquisitions by both companies, as well as ongoing clinical studies and next-generation devices in the pipeline.


Related Content

Heart Failure: Next-Gen VADs Fuel Optimism Amid Challenges
European Markets Show Pockets Of Strong Growth For Cardiovascular Devices
LVAD Companies Address Thrombosis Fears Raised In NEJM Report
HeartWare Adds Synergy Circulatory Support System With $30 Mil. CircuLite Buy
CMS Fields Many Suggestions And Criticisms On Proposed VAD Policy
CircuLite: Treating Heart Failure’s Lost Patients
Two Small Companies See Huge Opportunities In Heart Failure Device Space
Pressure Builds In Ventricular Assist Market
Heart Failure Devices: Raising Roadblocks To Readmission


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts